Copyright
©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1480-1494
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1480
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1480
Figure 3 Recurrence rate according to the value of Mac-2 binding protein and Mac-2 binding protein glycosylation isomer.
The hepatocellular carcinoma recurrence rate was divided into two groups according to the value of Mac-2 binding protein (M2BP) or M2BP glycosylation isomer (M2BPGi) before radiofrequency ablation. A: Hepatitis C virus (HCV)-positive group divided by M2BP value. The gray line indicates patients with M2BP < 5385 ng/mL, and the black line indicates patients with M2BP ≥ 5385 ng/mL; B: HCV-positive group divided by M2BPGi value. The gray line indicates patients with M2BPGi < 4.94 cutoff index (COI), and the black line indicates patients with M2BPGi ≥ 4.94 COI; C: HCV-negative group divided by M2BP value. The gray line indicates patients with M2BP < 2745 ng/mL, and the black line indicates patients with M2BP ≥ 2745 ng/mL; D: HCV-negative group divided by M2BPGi value. The gray line indicates patients with M2BP < 1.86 COI, and the black line indicates patients with M2BPGi ≥ 1.86 COI. HCV: Hepatitis C virus; M2BPGi: Mac-2 binding protein; M2BPGi: Mac-2 binding protein glycosylation isomer; NS: No significance.
- Citation: Nakai M, Morikawa K, Hosoda S, Yoshida S, Kubo A, Tokuchi Y, Kitagataya T, Yamada R, Ohara M, Sho T, Suda G, Ogawa K, Sakamoto N. Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma. World J Hepatol 2022; 14(7): 1480-1494
- URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1480.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1480